Search Results 2181-2190 of 12482 for Sertraline

  1. Digestive Diseases Update

    2022 Issues · The Role of Capsule Endoscopy in Diagnosis and Management of Inflammatory Bowel Disease · Examining the Clinical Presentation and Imaging ...

  2. Patient Stories - Morie A. Gertz, M.D. - Mayo Clinic

    Morie A. Gertz, M.D. · Hematologist · Internist · Oncologist · Chair, General Internal Medicine, Minnesota.

  3. Mayo Clinic

    Fund research. Save lives. · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & Financial ...

  4. A Study of the Test Results of Performing an Exhaled Nitric Oxide Before versus After Spirometry - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Neurosciences Clinical Trials - Medical Professionals

    Rochester, Minn. The purpose of this study is to prospectively evaluate the patient-reported outcomes data of T-DM1 induced peripheral neuropathy like prior ...

  6. Patient Stories - Kellie K. Kruger, M.D. - Mayo Clinic

    Fund research. Save lives. ... Benefactor support fuels Mayo Clinic's groundbreaking research. Make a gift today to help us save lives. Give Today.

  7. Patient Stories - Kevin I. Perry, M.D. - Mayo Clinic

    Kevin I. Perry, M.D.. Orthopedic Surgeon. Request an Appointment · Overview · Publications ...

  8. Personalized care - Mayo Clinic

    Mayo Clinic hematology experts take your needs and wishes into consideration when determining your treatment options.

  9. Patient Stories - Terence T. Sio, M.D., M.S. - Mayo Clinic

    Terence T. Sio, M.D., M.S. · Oncologist · Radiation Oncologist.

  10. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

    The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based ...